₹ 36.57 Cr
0.19%
NIFTY Healthcare TRI.
INF209KB10C2
500.0
0.0
1000
Ms. Priya Sridhar
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Aditya Birla Sun Life Nifty Healthcare ETF | 3.95 | 21.95 | - |
NIFTY Healthcare TRI | 4.21 | 21.97 | 17.13 |
Equity
Debt
Others
The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Healthcare TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Company | Holdings (%) |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 18.51 |
MAX HEALTHCARE INSTITUTE LIMITED EQ | 9.32 |
CIPLA LIMITED EQ NEW FV RS.2/- | 8.8 |
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.43 |
Dr. Reddys Laboratories Ltd | 7.78 |
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.62 |
LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.69 |
FORTIS HEALTHCARE LIMITED. EQ | 4.5 |
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.94 |
LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.44 |
Sector | Holdings (%) |
---|---|
Healthcare | 99.82 |
Scheme Name | 5Y (%) |
---|---|
ABSL Nifty Healthcare ETF | 0.0 |
Mirae Asset Hang Seng TECH ETF | 0.0 |
Nippon India ETF Hang Seng BeES | 5.35 |
Mirae Asset NYSE FANG and ETF | 0.0 |
LIC MF Gold Exchange Traded Fund | 13.0 |
Invesco India Gold ETF | 12.71 |
ICICI Pru Gold ETF | 12.61 |
Quantum Gold Fund | 12.39 |
ABSL Gold ETF | 12.59 |
Tata Gold ETF | 0.0 |